Skip to main content
Clinical Trials/CTRI/2023/07/055506
CTRI/2023/07/055506RecruitingPhase 2

To determine the effects of Artificial sweeteners & Nutritive sweetener on the gut microbiota and its influence on the length of telomere in the adult diabetic population: Open-Labelled Prospective Randomized Controlled Trial

MATCHA ANGELI0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Eligible participants (age >18 years) with type 2 diabetes
  • The participants who accept to adhere to the dietary plan and avoid consuming other sources
  • of artificial sweeteners will be considered

Exclusion Criteria

  • Patients with Type 1 Diabetes
  • Patients with Gestational Diabetes Mellitus
  • Patients with an History of non-tolerance to artificial sweeteners
  • Patients who consumed any artificial sweeteners prior to the study in the last 1
  • Patients with malignancy, or had undergone chemo radio therapy

Investigators

Sponsor
MATCHA ANGELI

Similar Trials